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Abstract Resumen 
Context: Spain was at the epicentre of the pandemic. Health centres 
across Spanish territory refused to respond to non-emergency enquiries, 
leaving community pharmacies as the first point of patient’s contact. 
Aims: To investigate the impact of COVID-19 on the mental and physical 
health of community pharmacy teams across Spain. 
Methods: A cross-sectional observational study was performed with 
community pharmacy professionals throughout Spain. A questionnaire 
designed by our collaborator from the United Kingdom was adapted to 
the Spanish population and launched between October 2020 and 
February 2021. 
Results: A total of 98 participants responded to the questionnaire. The 
survey showed an 80% increase in workload. The pandemic had 
negatively impacted the well-being of community pharmacy 
professionals. The survey indicated a national shortage of medicines 
and personal protective equipment across Spain, particularly during the 
first peak. To adapt to this pandora's box of COVID-19, 96% of the 
pharmacies changed their settings to improve patients and staff's safety. 
Most of these changes were self-financed by the pharmacy owner. The 
pharmacists kept up to date with information released from the 
pharmacists' college, General Pharmaceutical Council and the Spanish 
Society of Community Pharmacists. The Public domain purchased more 
(79%) immune booster supplements. 
Conclusions: Community pharmacy team have faced tremendous 
mental, physical and professional pressure in providing adequate 
personal protective equipment and medication supply to their 
communities. They have resisted delivering more pharmaceutical 
services during the crisis, because they have not been recognised as 
essential healthcare workers by the healthcare system.  
Contexto: España fue el epicentro de la pandemia. Los centros de salud 
de todo el territorio español se negaron a responder a consultas que no 
fueran de emergencia, dejando a las farmacias comunitarias como 
primer punto de contacto con los pacientes.  
Objetivos: Investigar el impacto del COVID-19 en la salud física y mental 
de los equipos de farmacia comunitaria en España. 
Métodos: Se realizó un estudio observacional transversal con 
profesionales de farmacia comunitaria de toda España. Un cuestionario 
diseñado por nuestro colaborador del Reino Unido fue adaptado a la 
población española y lanzado entre octubre de 2020 y febrero de 2021. 
Resultados: Un total de 98 participantes respondieron al cuestionario. La 
encuesta mostró un aumento del 80% en la carga de trabajo. La 
pandemia había tenido un impacto negativo en el bienestar de los 
profesionales de la farmacia comunitaria. La encuesta indicó una escasez 
nacional de medicamentos y equipos de protección personal en España, 
especialmente durante el primer pico. Para adaptarse a esta caja de 
pandora de COVID-19, el 96% de las farmacias cambiaron su 
configuración para mejorar la seguridad de los pacientes y del personal. 
La mayoría de estos cambios fueron autofinanciados por el propietario 
de la farmacia. Los farmacéuticos se mantuvieron al día con la 
información difundida por el colegio de farmacéuticos, el Consejo 
General Farmacéutico y la Sociedad Española de Farmacéuticos 
Comunitarios. El dominio público compró más (79%) suplementos de 
refuerzo inmunológico. 
Conclusiones: El equipo de farmacia comunitaria ha enfrentado una 
tremenda presión mental, física y profesional para proporcionar equipo 
de protección personal adecuado y suministro de medicamentos a sus 
comunidades. Se han resistido a prestar más servicios farmacéuticos 
durante la crisis, porque no han sido reconocidos como trabajadores 
sanitarios esenciales por el sistema sanitario.  
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INTRODUCTION 
COVID-19 was initially reported in late Decem-
ber 2019 in Wuhan (Guo et al., 2020). The World 
Health Organisation (WHO) named it coronavirus 
disease 2019 (COVID-19) on the 12th of February 
2020 and further declared it a global pandemic on 
March 11th  2020 after its unbelievably fast spread 
from its first epicentre (World Health Organiza-
tion, 2020a or b). The Spanish national government 
prohibited public gatherings, imposed restrictions 
on movement and other preventive and control 
measures such as mandatory masks in public 
spaces to decrease the infection rates. Despite all 
these preventative measures, widespread commu-
nity transmission led to a high hospitalisation rate 
across Spain like the rest of the world. Insufficient 
material and human resources led to waves of ex-
cess mortalities among the Spanish population 
during the pandemic. This crisis placed a tremen-
dous amount of pressure on the Spanish 
healthcare system, nearly driving it to the point of 
collapse with many healthcare centres closures. 17 
diverse and independent regional autonomies 
"Comunidades autónomas" in Spain decide about the 
healthcare policies and actions (Gastelurrutia et al., 
2020). The governmental body "Centro de Coordi-
nación de Alertas y Emergencias Sanitarias" is in 
charge of coordination and communicated among 
these regional entities (Legido-Quigley et al., 
2020).  The governmental entities then decided on 
Health Centres' closure and implemented medical 
consultations by videoconference. This left the 
pharmacies as the most accessible health estab-
lishment to attend patients in person. The latest 
reports showed there is a ratio of 4.7 pharmacies 
per 10,000 inhabitants in Spain. Out of 74,043 prac-
tising registered pharmacists, 87% (51,959 phar-
macists) worked in the community pharmacy 
(Portalfarma, 2016). Despite this, many health au-
thorities have not explicitly recognized the com-
munity pharmacy's work in the fight against the 
pandemic, nor have they contributed to providing 
these health facilities with the required personal 
protective equipment (PPE) (Community of Ma-
drid, 2020). It is noteworthy that community 
pharmacy interventional services are not commis-
sioned in Spain on a national level (Gastelurrutia 
et al., 2020). Despite the crisis, the population wit-
nessed a high level of resilience among pharma-
cists during the pandemic who were highly devot-
ed to the health of the people and worked side by 
side with other healthcare professionals to over-
come the barriers imposed by COVID-19. In the 
process, many pharmacists have lost their lives or 
been infected, leading to business closure and fi-
nancial loss (Fernández, 2020). Despite the Spanish 
community pharmacies professionalism and 
commitment to meeting patients' needs and main-
taining continuity of services during the pandem-
ic, they were not listed by the Coordination of 
Emergencies as health professionals in the risk 
groups. This led to a lack of government financial 
support for this sector during the pandemic (Ali-
aga Gutiérrez et al., 2020). 
No survey was conducted to investigate the 
immediate effect and obstacles imposed due to the 
pandemic on Spain's privately-owned pharmacy 
sector. This article mainly focuses on exploring the 
real impact of the COVID-19 pandemic on Spanish 
community pharmacists in privately owned 
pharmacy healthcare models. It will further help 
the healthcare system understand the challenges 
community pharmacy teams have faced during 
the COVID-19 pandemic in Spain and explored its 
impact on resources (i.e., personal protective 
equipment, medicines and staff). It also explored 
the relationship and means of communication (tel-
emedicine) used between community pharmacies, 
patients, and other healthcare professionals. It can 
provide an insight into the types of treatments 
patients bought over the counter to treat COVID-
19. Most importantly, it assesses the impact the 
pandemic has had on the mental wellbeing of 
pharmacy teams.  This research hopes to provide 
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some insight and valuable lessons for better prepa-
ration for future epidemiological crisis.  
MATERIAL AND METHODS 
Design of the study 
We have performed a cross-sectional observa-
tional study with Community Pharmacy profes-
sionals, including pharmacists, technicians or stu-
dents who were asked to complete a web-based 
questionnaire.  
Sample selection  
The study's inclusion criteria were, be a com-
munity pharmacist, pharmacy technician, or other 
pharmacy team member working in the communi-
ty setting during the COVID-19 outbreak who is 
based in Spain and over 18 years old. Responders 
who did not work in a community pharmacy dur-
ing the COVID-19 outbreak, pharmacists in other 
sectors such as hospital, industry and academia 
were not included in the survey. 
A non-random snowball sampling procedure 
was adopted. The researchers reached their social 
network for the study and invited the participants 
via an email or a message on various social net-
working platforms, including Facebook®, Twitter, 
WhatsApp and LinkedIn, to respond to the pre-
validated questionnaire. The participants were 
encouraged to share the survey with their profes-
sional networks as well. The selection bias was 
minimized by clearly defining the subpopulation 
of the study before the data collection. Also, some 
participants were contacted randomly through the 
phone directory or Google Map, who could not 
otherwise know about the survey since they were 
not part of the professional researcher network. 
Workplan 
The study was performed using It was a web-
based questionnaire designed by a British collabo-
rator Dr. Sukvinder Kaur Bhamra, piloted in a 
small group of volunteers, and launched in the UK 
to community pharmacy's professionals. This sur-
vey was translated into Spanish and adapted to 
the Spanish context. The investigators launched 
the web-based questionnaire between October 
2020 and February 2021. As a cloud-based survey 
powered by Google™, Google Forms was em-
ployed as a data collection tool. The google ac-
count belongs to the University of Complutense to 
further ensure the security of data storage. 
The self-completion survey consisted of 25-
items that explored the community pharmacist's 
view via a mixture of open and close-ended ques-
tions. The first section of the questionnaire investi-
gated the impact of the pandemic on pharmacist 
trainees. The subsequent sections explored the 
implications of the COVID-19 on: i) professional 
practice, including the impact on the workload or 
the difficulties/challenges; ii) material resources 
and information sources used to support the pa-
tient’s care and adaptation to COVID-19-derived 
safety requirements; iii) patients’ expectations and 
behaviour during the pandemic; iv) consumer’s 
habits on complementary and adjuvant therapies; 
v) pharmacy team emotional and physical wellbe-
ing and finally vi) sociodemographic characteris-
tics of the participants. 
Ethics approval and consent to participate 
The ethical committee of the University San 
Pablo CEU in Spain approved the study with reg-
istration number 457/20/36. Also, the research 
was conducted in full compliance with the Decla-
ration of Helsinki. At the beginning of the ques-
tionnaire, the investigator clearly described the 
study's nature, and all volunteers agreed to partic-
ipate. The research group protected the partici-
pants' professional confidentiality by making the 
responses anonymous. Involvement in the study 
was voluntary. Answers to the survey were kept 
anonymous. 
Statistical analysis 
Statistical analysis was performed using the 
STATA package version 12.0 (StataCorp LP, Col-
lege Station, TX, USA). Descriptive statistics were 
employed for the demographic findings. The re-
flective thematic analysis with the NVivo qualita-
tive data analysis software; QSR International Pty 
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Ltd. Version 12 was used for evaluating the open-
ended question. 
RESULTS 
A total of 98 individuals responded to the ques-
tionnaire distributed via Google Forms. The result 
of the survey showed the majority of responders 
were aged between 21-30 years (43%), female 
(77%) and Spanish (98%). This survey found more 
than half of the participants were based in Madrid 
(51%). The researcher included detailed sociodem-
ographic characteristics of participants in Table 1. 
Impact of COVID-19 pandemic on the well-being 
of the pharmacy teams 
A total of 78 (80%) pharmacists vs. 6 (6%) 
pharmacy assistants, 7 (7%) pharmacy technicians 
and one delivery staff responded to the question-
naire. As shown in Table 2, the most important 
finding of this study was that the majority of the 
participants (84%) experienced a negative impact 
on their mental health as direct result of the pan-
demic. Regarding the psychological impact of 
COVID-19, it must be highlighted that 82% of par-
ticipants feared to transmit the virus to their rela-
tives, a 32% reported difficulties to cope with fami-
ly pressure and some of them admitted feeling 
anxious (11%) or even depressed (3%). Also, 65% 
of the participants reported a negative impact on 
their physical health. They reported having suf-
fered from (in order of importance) tiredness, in-
somnia, weight lost, headache and worsening mi-
graine, muscle and back pain as well as worsening 
asthma, chest pain and dermatitis. 19% of individ-
uals reported to have contracted the virus and 
took sick leave during the five-month study peri-
od. The pharmacy teams reported a significant 
impact as well on the pharmacy practice. Indeed, 
67% claimed that the medical centres were inac-
cessible for patients in their locality, which in turn 
posed  extra  pressure  on  pharmacies.  The results  
 
Table 1. Sociodemographic characteristics of the pharmacy team participants. 
Characteristics N  Percentage (%)  Characteristics N  Percentage (%) 
Age groups    Location of responders    
21-30 42 42  Andalucía 4 4 
31-40 28 28  Aragón 1 1 
41-50 14 14  Principado de Asturias 18 18 
51-60 10 10  Balearic Islands  2 2 
>61 4 4  Canarias 5 5 
Gender    Cantabria 1 1 
Male 23 23  Castilla y León 3 3 
Female 75 76  Cataluña 1 1 
Years of experience     Comunidad Valenciana 1 1 
1-5 34 34  Extremadura 3 3 
6-10 19 19  Galicia 3 3 
11-20 17 17  Comunidad de Madrid 50 50 
21-30 14 14  Región de Murcia 2 2 
>31 8 8  Basque country  4 4 
Ethnicity        
Spanish  96 97     
African  1 1     
Asian  1 1     
Data are direct transfer of the Google form survey in Excel format. Total n = 98. 
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Table 2. Impact of COVID-19 on the community pharmacy team across Spain. 
Impact  Emerging reflective themes from the pharmacist’s responses* N Percentage (%) 
General  Perception of negative impact on mental health 84 84 
Psychological Fearful of transmitting the virus to their relatives 82 82 
Difficulty coping with family pressure  32 32 
Stress 15 15 
Anxious  11 11 
Physical and psychological pressure 12 12 
Fear  7 7 
Nervousness 3 3 
Exhaustion  3 3 
Depressed  3 3 
Uncertainty 2 2 
Patient aggression and abuse  2 2 
Overworked 2 2 
Difficulty in sleep 2 2 
Collapsed 1 1 
Uncontrolled chronic condition in patients 1 1 
Crying patients  1 1 
Confrontation and conflict with patients 1 1 
Physical Physical impact of COVID-19 on pharmacists  65 65 
Tiredness  32 32 
Insomnia  20 20 
Contracted the COVID-19 virus 19 19 
Weight lost  17 17 
Headache  5 5 
Muscle and back pain 5 5% 
Worsening chronic conditions  5 5% 
Asthma, chest pain and dermatitis 1 1 
Pharmacy Practice Extra pressure on pharmacies due to the inaccessibility of medical 
centres for patients  
67 67 
Increased workload 80 80 
Home care 10 10 
Home delivery 5 5 
Increase telephone consultation  4 4 
More involvement in pharmaceutical care and diagnosis and treatment 
of minor symptoms  
4 4 
Decrease in sale 1 1 
Calling the patient who lived alone daily 2 2 
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Table 2. Impact of COVID-19 on the community pharmacy team across Spain (continued…). 




Felt proud to be a member of the pharmacy profession 58 58 





Stock-out of the medicines  2 2 
Work in public holidays 1 1 
Complication 1 1 
Theft  1 1 
Other emerging 
problems 
Pandemic has compromised patient’s care for chronic conditions  81 81 
Problems in accessing correct information in relation to the pandemic 10 10 
Lack of personal protective equipment (PPE) 10 10 
Long patient’s queues  2 2 
Combating false news 2 2 
Closure of health centre 2 2 
Lack of patients trust in masks and gel sold over the counter  1 1 
Educating patients and elderlies about the pandemic 1 1 
Data are direct transfer of the Google form survey in Excel format. Total n = 98. *The search was performed by NVivo on the exact match or 
stemmed words throughout the pharmacy team’s responses. 
 
 
Figure 1. Word cloud of the Spanish 
community pharmacy’s response in 
relation to COVID-19 pandemic. 
 
suggested that emotional and physical pressure 
caused by the pandemic made 26% of pharmacists 
reconsider their carrier choice. The majority of the 
responders (80%) claimed that the pandemic had 
increased their workload. 81% of the participants 
felt that the pandemic had compromised the pa-
tient with long-term comorbidities. On a positive 
note, 58% felt proud to be a member of the phar-
macy profession, and 31% were strong and moti-
vated to advance and provide the best pharmaceu-
tical care to their patients. However, 81% of the 
participants declared a significant impact of the 
pandemic on patient’s care for chronic conditions 
together with other problems such as the lack of 
personal protective equipment (PPE) or reliable 
information (Table 2).  
The word cloud created from these responses 
shown in Table 2 can be found in Fig. 1. 
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Table 3. Sources of emotional and professional support for the pharmacy team during the COVID-19 pandemic in Spain. 
Support for pharmacy 
team  
Sources  Percentage 
(%) 
Emotional  Family  93 
Friends  85 
Pharmacy manager  34 
Professional  Pharmaceutical society 67 
College of the Pharmacists from their regional autonomies 67 
Counsel of Official Associations of Pharmacists (Consejo General de Colegios 
Oficiales de Farmacéuticos) 
65 
Department of Health 57 
Pharmacy managers 48 
Pharmacy colleagues in social and professional networks 31 
 
Pharmacist’s emotional support 
The pharmacy team described having received 
a high level of personal support from their family 
(93%), friends (85%) and pharmacy manager 
(34%), as shown in Table 3. Further, the majority of 
the respondents have obtained professional sup-
port from the pharmaceutical society (67%), The 
College of the Pharmacists from their regional au-
tonomies (67%), General Counsel of Official Asso-
ciations of Pharmacists (Consejo General de Colegios 
Oficiales de Farmacéuticos, 65%), Department of 
Health (57%), pharmacy managers (48%) and other 
pharmacy colleagues in social and professional 
networks (31%) (Table 3). 
The national shortage of medication and 
equipment across Spain and the support received  
The researchers have summarized the commu-
nity pharmacy team’s response to the national 
shortage of medication and equipment experi-
enced during the first wave of the pandemic in 
Spain in Table 4. The study finding indicates that 
paracetamol, hydrogen peroxide, vitamin C and D 
were shortlisted during the pandemic in the medi-
cine category. Also, a shortage of appliances such 
as masks, gloves and alcohol gel were seen in the 
pharmacy during the pandemic. Most importantly 
insufficient dissemination of information about the 
COVID-19 and health centres closure made pa-
tient’s care difficult. The survey shows that 8% of 
pharmacist believe the cost of medications during 
the pandemic increased. This could be due to na-
tional shortages or the 54% of patients found to be 
stockpiling the medicines. 
Change in pharmaceutical care protocol or 
pharmacy setting 
A high percentage of participants of the partici-
pants (96%) reported changes in the pharmacy 
setting to improve the safety of patients and staff. 
The main adaptations made were included in Ta-
ble 5. A high number of pharmacies (76%) con-
firmed buying personal protective equipment 
(PPE) out of pocket. Other pharmacists claimed to 
receive PPE and disinfectants from the College of 
Pharmacists in Madrid “Official College of Phar-
macists of Madrid” (COFM), Official College of 
Pharmacists of Asturias “Official College of Phar-
maceutics of Asturias (COF)”, private laboratories, 
neighbouring dentists as well as some private in-
dustries such as COFARES “Fundación Cofares”, 
Bidafarma and Pharmaceuticals MIA. The majority 
of the pharmacists (n = 50, 51%) have used the 
pharmacists' official college in their autonomous 
community as a source of reliable information 
throughout the pandemic. Other widely used re-
sources were the General pharmaceutical council 
in Spain (32%), the Spanish society of community 
pharmacists known as “Sociedad Española De Far-
macia Comunitaria SEFAC” (15%), Ministry of 
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Health live updates and The Asturian Pharmaceu-
tical Cooperative (COFAS) in Spain.  
The pharmacists claimed to mostly refer pa-
tients to the COVID-19 Hotline (70), the nearest 
health centre (40) and Ministry of Health docu-
ments (37) for obtaining information (Fig. 2A). 
Some of the pharmacy team believed they were 
adequately prepared to combat the pandemic 
(31%) vs. the majority who thought they were par-
tially prepared (42%). Others felt unprepared due 




Table 4. National shortage of medicine or alliances due to COVID-19 pandemic across community pharmacies in Spain. 
Shortage and limitations  Emerging reflective themes from the pharmacist’s responses* N  Percentage (%) 
Medications Paracetamol  9 9 
Hydrogen peroxide  7 7 
Vitamin C 5 5 
Vitamin D 5 5 
Hydroxychloroquine or chloroquine   5 5 
Antibiotics  1 1 
Antipyretics  1 1 
Anxiolytics  1 1 
Betamethasone 1 1 
Antiviral  1 1 
Tamiflu 1 1 
Ventolin (salbutamol)  1 1 
Plavix  1 1 
Appliances Mask  44 44 
Gloves 24 24 
Alcohol Gel 15 15 
Personal protective equipment 14 14 
Medicines  5 5 
Thermometers  6 6 
Disinfectant  2 2 
Antibody test kit or rapid test kit for COVID-19 1 1 
Others Lack of information  6 6 
 Lack of access to doctors due to closure of medical centres  2 2 
Data are direct transfer of the Google form survey in Excel format. Total n = 98. 
*The search was performed by NVivo on the exact match or stemmed words throughout the pharmacy team’s responses. 
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Table 5. Adaptation made across community pharmacies out of pocket during the first peak of the COVID-19 in Spain. 
Adaptation made to  Emerging reflective themes from the pharmacist’s responses* N  Percentage (%) 
Pharmacy settings Protective counter  38 38 
Gel dispenser  15 15 
Air purification  6 6 
Protective screen instalment in the pharmacy counter  6 6 
Partition  7 7 
Separation signs and sticker for patients  5 5 
Barriers at the entrance to avoid patients entering the pharmacy 3 3 
Buying new computers to avoid cross contamination between staff 1 1 
Refurbishing the pharmacy setting  1 1 
Protocols Social distancing  20 20 
Compulsory use of mask in the pharmacy premises  18 18 
Special cleaning protocol   9 9 
Compulsory use of gloves for staff  6 6 
Compulsory use of alcohol gel for patients and staff  6 6 
Signposting protocol for patient unable to access the medical centre 3 3 
Staffing Change in shifts of the staff to avoid contamination 12 12 
Data are direct transfer of the Google form survey in Excel format. Total n = 98. 





Figure 2. (A)  Bar chart showing the sources to which patients have been referred to obtain 
reliable information about COVID-19-related issues. (B) Circle chart showing the pharmacy 
teams’ perception about their level of preparation to combat the pandemic. 
 
Patient’s attitude towards the pharmacy  
About 47% of the participants claimed that pa-
tients developed a more positive attitude towards 
the pharmacy team due to the pandemic, 59% 
claimed that the patient developed a more positive 
attitude because of the services provided by the 
pharmacist and 44% of the responders stated that 
individual expected the pharmacy to give medica-
tion to them without a prescription (Table 6). Fur-
ther, 59% offered emotional support to the clients. 
79% of the participants claimed to have more in-
quiries on supplements during the pandemic's first 
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peak. The summary of these supplements sold 
over the counter in the pandemic's first peak for 
prevention, treatment, and recovery of the 
COVID-19 infection is shown in Table 7. The 
pharmacists claimed that the products with a sig-
nificant increase in demand were chloroquine, 
antiviral and paracetamol requested over the 
counter for treatment of the virus. Also, 64% in-
crease in the sleeping aids were observed.  Vita-
mins C, D, and B and immune system boosters 
were also purchased in excess. Echinacea, propolis 
and phytotherapy purchase was also observed to 
be increased during the pandemic. The increase 
demand in homeopathic solutions and mouthwash 
was seen. The pharmacists reported a 55% increase 
in the purchase of respiratory medicines such as 
inhalers, cough syrups, decongestants and antihis-
tamines during the crisis. 
 
 
Table 6. Patient’s attitude and behaviour towards community pharmacy profession in Spanish territory. 
Impact of pandemic on 
patient’s behaviour  
Emerging reflective themes from the pharmacist’s 
responses* 
Frequency   Percentage 
(%) 
Emotion and behaviour Nervous  7 7 
 Anxious 4 4 
 Fearful 4 4 
 Uncertain 4 4 
 Impatient 3 3 
 Irritable 3 3 
 Aggressive 2 2 
 Depressed 2 2 
 Insomnia 2 2 
 Stressed 2 2 
 Defensive, disrespectful, emotional, empathetic, forgetful, 
helpless, hostile, negative, rushed, scared, worsening 
schizophrenia, selfish, sensitive, supportive, suspicious 
towards gel and mask sold in the pharmacy, upset 
1 1 
General image from  Patient’s satisfaction with pharmacy services 59 59 
pharmacy profession Positive attitude towards the pharmacy team 47 47 
 Confidence in community pharmacist’s knowledge to 
respond to their symptoms and treat accordingly 
10 10 
 Grateful that pharmacies are open and accessible 12 12 
Expectations  Demanded prescription only medicine (POM) without valid 
prescription  
44 44 
*The search is a result of reflective thematic analysis performed by NVivo software on the exact match or stemmed words throughout the 
pharmacy team’s responses.  
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Table 7. Supplements and medicines requested by the patients for the prevention or chronic phase of the COVID-19 infection to be sold over the counter. 
Requested  Prevention* N Percentage % Treatment* N Percentage % Recovery* N Percentage % 
Medicines Antiviral  1 1 Chloroquine 6 6 Sleep aid  64 64 
Anxiolytic  1 1 Antiviral  3 3 Anxiolytic  1 1 
Chloroquine  1 1 Paracetamol  3 3 Chloroquine 1 1 
   Antiparasitic  1 1 Creams for 
muscle pain  
1 1 
   Corticosteroid  1 1 Infusions  1 1 
   Infusions  1 1 Spray for nose 
decongestant  
1 1 
Supplements Vitamins C, D, B 49 49 Vitamins C, D, B 9 9 Vitamins C, D, B 17 17 
Immune system 
booster 
17 17 Immune system 
booster 
3 3 Immune system 
booster 
2 2 
Food supplement  3 3 Omega 3 1 1 Food 
supplements  
2 2 
Multivitamins 5 5 Inspirulin  1 1 Zinc  2 2 
Melatonin  2 2 Zinc  1 1 Calcium  1 1 
Zinc 2 2    Collagen  1 1 




Selenium  1 1    Magnesium   1 1 
       Manganese  1 1 
       Melatonin  1 1 
       Probiotics 1 1 
       Selenium  1 1 
       Sustenium Plus 1 1 
Herbal Echinacea  12 12 Echinacea  5 5 Echinacea  3 3 
 Propolis  4 4 Propolis  4 4 Phytotherapy 3 3 
 Phytotherapy 3 3 Phytotherapy 2 2 Royal Jelly 1 1 
 Garlic  2 2 Peppermint  1 1    
 Ginger  1 1 Turmeric  1 1    
 Royal Jelly  1 1 Ginseng  1 1    
Homeopathy Homeopathic 
solutions 
4 4 Homeopathic 
solutions 
3 3    
Disinfectants Mouthwash  3 3 Miracle Mineral 
Solution (MMS) 
2 2    
 Hydrogen 
peroxide  
2 2 Alcohol gel  1 1    
Aromatherapy    Aromatherapy 1 1 Aromatherapy 1 1 
Data are direct transfer of the Google form survey in Excel format. *The search was performed by NVivo on the exact match or stemmed words throughout 
the pharmacy team’s responses. 
Manouchehri et al. Impact of COVID-19 on the community pharmacy team 
 
http://jppres.com/jppres  J Pharm Pharmacogn Res (202x) x(x): 12 
 
DISCUSSION 
This study aimed to investigate the impact of 
the crisis on pharmacy practice, patients’ attitude, 
pharmaceutical purchases, and the CPT's emotion-
al and physical well-being in Spain. The pharmacy 
team reported a tremendous physical and emo-
tional pressure, leading to stress, fear, nervous-
ness, mental and physical exhaustion, and uncer-
tainty about the future. Many participants report-
ed their chronic condition, such as migraine, asth-
ma or dermatitis deteriorated. A plausible expla-
nation may be the significant increase in pharmacy 
team workload, which had left little time for re-
covery, quality time with family or exercising. It 
appears that other research groups have also re-
ported a similar burden on healthcare workers 
across the world (Mehta et al., 2021). The Spanish 
pharmacy team affirmed receiving little support 
from the health authorities despite the enormous 
effort made. Some felt abandoned and neglected 
by the government. Some were "attacked" by the 
population who think of pharmacy as a private 
sector. These negative experiences, added to the 
workload, had an unfortunate effect on profes-
sional’s mental health. However, the community 
pharmacy team resisted and withstood the pres-
sure like all their counterparts across the world 
(Felice et al., 2020). The pharmacies have adopted 
new practices such as home care, home delivery, 
telephone consultation, pharmaceutical care and 
responding to symptoms. Some even reported 
going beyond their professional duty by calling 
the patient who lived alone, daily. The pharmacy 
team made changes in daily protocol and setting 
to meet the demand of the crisis. An increase in the 
operation hours, purchase of PPE out of pocket 
and segregating shifts to avoid cross-
contamination were examples of these alterations. 
The majority of pharmacies reported difficulties 
obtaining PPE at the beginning of the crisis; how-
ever, a shortage of PPE was observed worldwide 
(Cohen and Rodgers, 2020; Ranney et al., 2020). 
This could be in response to national shortages or 
54% of the patients who were found to be stockpil-
ing the medicines and PPEs. Many Spanish phar-
macies reported extended use or reprocessing of 
the PPE in line with World Health Organisation 
guidelines (World Health Organization, 2020 a or 
b?). Abedrabboh et al. (2021) have theorised better 
supply management such as early stockpiling in 
pharmacy and increasing storage capacities can 
improve future pandemic responses.  
Pharmacists claimed to spend many hours on 
continuous professional development (CPD) to 
improve their competencies. They employ their 
therapeutical expertise to educate the general pub-
lic and combat false news. This essential educative 
role of the community pharmacy team has been 
observed worldwide during the pandemic and 
beyond (Cadogan and Hughes, 2020; Liu et al., 
2020).  
CPs used the official college of pharmacists in 
their Autonomous community, General pharma-
ceutical council (CGCOF) and Spanish society of 
community pharmacists (SEFAC) guidelines as a 
reliable source of information, similar to their in-
ternational counterparts (International Pharmaceu-
tical Federation, 2020; Royal Pharmaceutical Socie-
ty, 2021). However, CPs requested better commu-
nication and joint action to be released earlier by 
health authorities in future incidences. Evidence 
showed that effective communication between 
pharmacists and other healthcare professionals can 
support continuity of care (Herzik and Bethishou, 
2021). 
The negative impact of COVID-19 made the pa-
tient nervous, anxious and fearful, uncertain, im-
patient, irritable, aggressive, depressed, suffer in-
somnia, stressed, defensive, disrespectful, emo-
tional, empathetic, forgetful, helpless, hostile, 
rushed, scared, sensitive, suspicious towards gel 
and masks sold in the pharmacy etc. In addition, 
pharmacists reported spending less time deliver-
ing traditional pharmaceutical care to the patients 
with chronic conditions due to more workload.  
Similar results were reported by CPTs in the Neth-
erlands who not conducted medication reviews 
during the pandemic (Koster et al., 2021). On a 
positive note, CP stated patients were grateful for 
significantly expanding access to care provided by 
the pharmacy. They demonstrated confidence in 
the pharmacist’s therapeutical expertise. The most 
purchased medicines for prevention, treatment or 
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recovery of COVID-19 across Spain were vitamins 
C, D, B and immune booster supplements and 
herbal medicines such as Echinacea, Propolis and 
Phytotherapy. Similar results were reported by 
Polish researchers (Karbownik et al., 2020). Phar-
macists reported conflict with patients due to their 
demand for Prescription Only Medicines (POM) 
such as antivirals, anxiolytics and chloroquine 
(General Pharmaceutical Council of Spain, 2013). 
In this scenario, participants requested the CGCOF 
and SEFAC to defend the pharmacy profession 
and recognize their continuous contribution as 
healthcare professionals and identify them as es-
sential services. Although the population sample 
was from all across Spain varying in age and level 
of experience, some other pharmacist’s experienc-
es or opinions might have been different, thus, the 
results must be interpreted with caution. Further 
studies characterizing the ongoing community 
pharmacists struggles as result of the pandemic 
may reveal whether these emotional and physical 
impacts were short lived or whether pharmaceuti-
cal care stayed in demand even after the crisis. 
CONCLUSIONS 
This study outlined the tremendous physical 
and mental pressure CPTs encountered as a pri-
vate sector during the first peak of the pandemic 
and beyond. This is consistent with previous data 
published on the impact of pandemic on health 
care professionals. Further studies are required to 
explore the impact of utilizing pharmacists’ exper-
tise on a wider scale during pandemics. Additional 
research is required to clarify the impact of giving 
pharmacists the permission to access a patient’s 
medical record, legalization of medication delivery 
by CP across Spain and improve communication 
between pharmacy and primary care. In conclu-
sion, an increase in demand for pharmaceutical 
services across Spain due to the pandemic, opened 
the eyes of many to the importance of community 
pharmacies as a health profession. 
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